Loading...
Loading...
India accounts for a significant share of global Ofloxacin exports, with 1094+ registered manufacturers shipping to buyers across 180+ countries — yet a handful of companies dominate the shipments. DR REDDYS LABORATORIES LIMITED holds the largest share at 10.1% (export value: $29.8M). Close behind, DR.REDDY'S LABORATORIES LTD (7.4%, $21.8M). MACLEODS PHARMACEUTICALS LTD (5.2%, $15.5M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
Comprehensive supplier network intelligence dashboard
Flow of Ofloxacin from leading Indian exporters to their key global customers
Top Suppliers → Customer Networks
The Ofloxacin export market from India is led by DR REDDYS LABORATORIES LIMITED, which alone commands a 10.1% share, shipping $29.8M worth of product across 26 shipments. The second-largest exporter, DR.REDDY'S LABORATORIES LTD, contributes $21.8M (7.4%) to the overall market. Combined, the top two suppliers alone account for 17.5% of all Ofloxacin exports, indicating a relatively concentrated supply base.
Across all 1094 tracked manufacturers, the total Ofloxacin export value stands at $295.2M from 15.0K shipments. The market average shipment value is $19.7K. The single largest buyer relationship in terms of trade value is DR, REDDYS LABORATORIES, INC, receiving $28.3M worth of product.
The combined buyer network spans 19 named purchasing companies, including DR, REDDYS LABORATORIES, INC, NORTHSTAR DISTRIBUTION CENTRE 8912, DELTA IMPORT - EXPORT MEDICAL CO,, NATIONAL DEPARTMENT , FE ADVANCE PHARMACEU and 14 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
DR REDDYS LABORATORIES LIMITED is the first-largest Ofloxacin exporter from India, with a market share of 10.1% and a total export value of $29.8M across 26 shipments. Their average shipment value of $1.1M is above the market average of $19.7K, suggesting premium or bulk contract pricing.
DR REDDYS LABORATORIES LIMITED serves 3 named buyers in our database. DR, REDDYS LABORATORIES, INC is the dominant customer, accounting for 95.1% of this supplier's tracked business. Top customers include:
• DR, REDDYS LABORATORIES, INC — $28.3M across 25 shipments (95.1% of this supplier's total exports)
• NORTHSTAR DISTRIBUTION CENTRE 8912 — $1.3M across 1 shipments (4.5% of this supplier's total exports)
• DR, REDDYS LABORATORIES, INC — $119.5K across 0 shipments (0.4% of this supplier's total exports)
Key Insight: DR REDDYS LABORATORIES LIMITED's per-shipment value of $1.1M is 5715% above the market average of $19.7K, consistent with large-order contracts or value-added formulations.
DR.REDDY'S LABORATORIES LTD is the second-largest Ofloxacin exporter from India, with a market share of 7.4% and a total export value of $21.8M across 74 shipments. Their average shipment value of $294.6K is
Once Ofloxacin leaves the manufacturing plants of companies like DR REDDYS LABORATORIES LIMITED and DR.REDDY'S LABORATORIES LTD, it travels to 5 destination markets with a combined import value of $295.2M. United States absorbs the largest share at 39.2% ($115.8M), followed by Vietnam (6.8%) and Russia (4.5%).
In United States — the top destination — named importers include DR REDDYS LABORATORIES INC, DR, REDDYS LABORATORIES, INC, NORTHSTAR DISTRIBUTION CENTRE 8912. In Vietnam, key buyers are DELTA IMPORT - EXPORT MEDICAL CO,.
This geographic spread reflects Ofloxacin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
Comprehensive geographic market intelligence dashboard
Trade flow of Ofloxacin exports from India — top destination countries and the named companies importing it
Top Countries → Global Importers
United States ranks as the first-largest destination for Ofloxacin imports from India, with a total trade value of $115.8M across 337 shipments — representing a 39.2% share of all Ofloxacin exports. The average shipment value of $343.5K is above the global average of $19.7K, indicating high-value procurement contracts or branded formulations. This market is served by 10 tracked buyers.
Named Ofloxacin importers in United States: DR REDDYS LABORATORIES INC is the largest buyer, accounting for 26.0% ($30.1M) of this market's total imports.
• DR REDDYS LABORATORIES INC — $30.1M (26.0% of United States's total)
• DR, REDDYS LABORATORIES, INC — $23.5M (20.3% of United States's total)
• NORTHSTAR DISTRIBUTION CENTRE 8912 — $9.9M (8.5% of United States's total)
Key Insight: United States's per-shipment average of $343.5K (1645% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Ofloxacin imports from India.
Visual overview of India's ofloxacin supply chain network — top suppliers, destinations, pricing, and trade routes
This video covers India's ofloxacin pharmaceutical supply chain network — $295.2M in total trade, 180 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.
Latest developments and market context
Detailed market intelligence for Ofloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
DR.REDDY'S LABORATORIES LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• DR, REDDYS LABORATORIES, INC — $8.9M across 30 shipments (40.6% of this supplier's total exports)
• DR, REDDYS LABORATORIES, INC — $7.1M across 24 shipments (32.7% of this supplier's total exports)
• NORTHSTAR DISTRIBUTION CENTRE 8912 — $2.7M across 9 shipments (12.3% of this supplier's total exports)
• NORTHSTAR DISTRIBUTION CENTRE 8912 — $2.7M across 9 shipments (12.2% of this supplier's total exports)
• DR, REDDYS LABORATORIES, INC — $455.0K across 2 shipments (2.1% of this supplier's total exports)
Key Insight: DR.REDDY'S LABORATORIES LTD's per-shipment value of $294.6K is 1397% above the market average of $19.7K, consistent with large-order contracts or value-added formulations.
MACLEODS PHARMACEUTICALS LTD is the third-largest Ofloxacin exporter from India, with a market share of 5.2% and a total export value of $15.5M across 243 shipments. Their average shipment value of $63.8K is above the market average of $19.7K, suggesting premium or bulk contract pricing.
MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. DELTA IMPORT - EXPORT MEDICAL CO, is the dominant customer, accounting for 75.7% of this supplier's tracked business. Top customers include:
• DELTA IMPORT - EXPORT MEDICAL CO, — $11.7M across 184 shipments (75.7% of this supplier's total exports)
• NATIONAL DEPARTMENT — $1.6M across 25 shipments (10.1% of this supplier's total exports)
• FE ADVANCE PHARMACEU — $1.1M across 18 shipments (7.3% of this supplier's total exports)
• ZUHOOR ELHAM LTD — $588.7K across 9 shipments (3.8% of this supplier's total exports)
• BRANCH COMPANY MACLE — $472.0K across 7 shipments (3.0% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $63.8K is 224% above the market average of $19.7K, consistent with large-order contracts or value-added formulations.
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fourth-largest Ofloxacin exporter from India, with a market share of 3.7% and a total export value of $11.1M across 202 shipments. Their average shipment value of $54.7K is above the market average of $19.7K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• SUN PHARMACEUTICAL INDUSTRIES,INC. — $3.8M across 70 shipments (34.5% of this supplier's total exports)
• AO RANBAXY — $3.3M across 60 shipments (29.9% of this supplier's total exports)
• SUN PHARMACEUTICAL INDUSTRIES,INC. — $1.8M across 33 shipments (16.3% of this supplier's total exports)
• TARO PHARMACEUTICALS — $1.1M across 21 shipments (10.4% of this supplier's total exports)
• M S AO RANBAXY — $977.7K across 18 shipments (8.8% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $54.7K is 178% above the market average of $19.7K, consistent with large-order contracts or value-added formulations.
AUROBINDO PHARMA LTD is the fifth-largest Ofloxacin exporter from India, with a market share of 1.0% and a total export value of $2.9M across 172 shipments. Their average shipment value of $17.1K is below the market average of $19.7K, reflecting a high-volume, competitive pricing strategy.
AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• AUROLOGISTICS LLC (A — $1.3M across 77 shipments (45.0% of this supplier's total exports)
• AUROLOGISTICS LLC — $631.6K across 37 shipments (21.5% of this supplier's total exports)
• AUROLOGISTICS LLC (A — $366.2K across 21 shipments (12.5% of this supplier's total exports)
• APL SWIFT SERVICES ( — $333.3K across 19 shipments (11.3% of this supplier's total exports)
• AUROBINDO PHARMA USA — $285.9K across 17 shipments (9.7% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (172 shipments) at a per-shipment value of $17.1K, indicating a broad distribution network with many smaller, regular orders.
MICRO LABS LIMITED is the fifth-largest Ofloxacin exporter from India, with a market share of 0.8% and a total export value of $2.5M across 373 shipments. Their average shipment value of $6.6K is below the market average of $19.7K, reflecting a high-volume, competitive pricing strategy.
MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• E P DIS — $769.1K across 116 shipments (31.2% of this supplier's total exports)
• LABOREX UGANDA LIMIT — $517.6K across 78 shipments (21.0% of this supplier's total exports)
• DANANG PHARMACEUTICA — $417.3K across 63 shipments (16.9% of this supplier's total exports)
• DANANG PHARMACEUTICA — $399.2K across 60 shipments (16.2% of this supplier's total exports)
• MICRO NOVA PHARMACEU — $361.0K across 55 shipments (14.7% of this supplier's total exports)
Key Insight: MICRO LABS LIMITED operates with high shipment frequency (373 shipments) at a per-shipment value of $6.6K, indicating a broad distribution network with many smaller, regular orders.
Vietnam ranks as the second-largest destination for Ofloxacin imports from India, with a total trade value of $20.0M across 4 shipments — representing a 6.8% share of all Ofloxacin exports. The average shipment value of $5.0M is above the global average of $19.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Ofloxacin importers in Vietnam: DELTA IMPORT - EXPORT MEDICAL CO, is the largest buyer, accounting for 59.7% ($11.9M) of this market's total imports.
• DELTA IMPORT - EXPORT MEDICAL CO, — $11.9M (59.7% of Vietnam's total)
Key Insight: Vietnam's per-shipment average of $5.0M (25322% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Vietnam is a key market for Ofloxacin imports from India.
Russia ranks as the third-largest destination for Ofloxacin imports from India, with a total trade value of $13.3M across 90 shipments — representing a 4.5% share of all Ofloxacin exports. The average shipment value of $147.8K is above the global average of $19.7K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Ofloxacin importers in Russia: LLC SENTISS RUS is the largest buyer, accounting for 40.2% ($5.3M) of this market's total imports.
• LLC SENTISS RUS — $5.3M (40.2% of Russia's total)
• AO RANBAXY — $3.5M (26.1% of Russia's total)
Key Insight: Russia's per-shipment average of $147.8K (651% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Russia is a key market for Ofloxacin imports from India.
Nigeria ranks as the fourth-largest destination for Ofloxacin imports from India, with a total trade value of $13.3M across 33 shipments — representing a 4.5% share of all Ofloxacin exports. The average shipment value of $402.1K is above the global average of $19.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Ofloxacin importers in Nigeria: FIDSON HEALTHCARE PLC is the largest buyer, accounting for 22.3% ($3.0M) of this market's total imports.
• FIDSON HEALTHCARE PLC — $3.0M (22.3% of Nigeria's total)
Key Insight: Nigeria's per-shipment average of $402.1K (1943% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Nigeria is a key market for Ofloxacin imports from India.
France ranks as the fifth-largest destination for Ofloxacin imports from India, with a total trade value of $8.7M across 0 shipments — representing a 3.0% share of all Ofloxacin exports. The average shipment value of $8.7M is above the global average of $19.7K, indicating high-value procurement contracts or branded formulations.
Key Insight: France's per-shipment average of $8.7M (44169% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
France is a key market for Ofloxacin imports from India.
Top supplier: 3 customers
6 suppliers → 180 countries
Network value: $295.2M
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
15,000 Verified Shipments
1094 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists